BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
US Army
Harvard Business School

Generated: March 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 016862

« Back to Dashboard

NDA 016862 describes DARVON-N, which is a drug marketed by Aaipharma Llc and Xanodyne Pharm and is included in four NDAs. Additional details are available on the DARVON-N profile page.

The generic ingredient in DARVON-N is aspirin; propoxyphene napsylate. There are twenty-one drug master file entries for this compound. Additional details are available on the aspirin; propoxyphene napsylate profile page.
Summary for 016862
Applicant:Xanodyne Pharm
Ingredient:propoxyphene napsylate
Therapeutic Class:Analgesics
Formulation / Manufacturing:see details

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength100MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Argus Health
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.